Yonsei Medical Journal · 2017 · 29 citations · 20 references
Life SciencesImmunologyOncologyApoptosisInnate ImmunityMolecular ImmunologyAntiviral ImmunityCytokine BiologyInflammatory SignalingInterferon ResponsesMultiple MyelomaToll-like ReceptorsCell Proliferation IndicesInflammatory Cytokine ProductionInflammatory Cytokine ProfilesInflammatory Cytokine SecretionInhibition Of Interferon ResponsesMyeloma PathogenesisToll-like Receptor SignalingType Iii Interferon Signaling
PURPOSE: Tripartite-motif-containing protein 56 (TRIM56) has been found to exhibit a broad antiviral activity, depending upon E3 ligase activity. Here, we attempted to evaluate the function of TRIM56 in multiple myeloma (MM) and its underlying molecular basis. MATERIALS AND METHODS: TRIM56 expression at the mRNA and protein level was measured by qRT PCR and western blot analysis. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and flow cytometry analysis was performed to investigate the effect of TRIM56 on MM cell proliferation and apoptosis. The concentrations of interferon (IFN)-β, interleukin (IL)-6, and tumor necrosis factor-α in MM cell culture supernatants were detected with respective commercial ELISA kits. Western blot was employed to determine the effect of TRIM56 on toll-like receptor 3 (TLR3)/toll-IL-1 receptor (TIR) domain-containing adaptor inducing IFN-β (TRIF) signaling pathway. RESULTS: TRIM56 expression was prominently decreased in MM cells. Poly (dA:dT)-induced TRIM56 overexpression in U266 cells suppressed proliferation, induced apoptosis, and enhanced inflammatory cytokine production, while TRIM56 knockdown improved growth, diminished apoptosis, and inhibited inflammatory cytokine secretion in RPMI8226 cells. Moreover, TRIM56 knockdown blocked TLR3 signaling pathway. Furthermore, poly (I:C), a TLR3 agonist, markedly abolished TRIM56 depletion-induced increase of proliferation, decrease of apoptosis, and reduction of inflammatory factor in MM cells. CONCLUSION: TRIM56 may act as a tumor suppressor in MM through activation of TLR3/TRIF signaling pathway, contributing to a better understanding of the molecular mechanism of TRIM56 involvement in MM pathogenesis and providing a promising therapy strategy for patients with MM.
20
The Ubiquitin Ligase TRIM56 Regulates Innate Immune Responses to Intracellular Double-Stranded DNA
Tetsuo Tsuchida, Jian Zou, Tatsuya Saitoh et al. · Immunity · 2010 · 491 citations · Full text
TLR3 Can Directly Trigger Apoptosis in Human Cancer Cells
Bruno Salaun, Isabelle Coste, Marie‐Clotilde Rissoan et al. · The Journal of Immunology · 2006 · 473 citations · Full text
Life Sciences, Immunology, Oncology +14
Toll-like receptors mediate proliferation and survival of multiple myeloma cells
Janne Ø. Bohnhorst, T. Rasmussen, Siv Helen Moen et al. · Leukemia · 2006 · 146 citations